Artwork

Content provided by Qualio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Qualio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Advancing Cancer Diagnostics with Mark McDonough, CEO of Chromacode

20:35
 
Distribuie
 

Manage episode 402773211 series 2833485
Content provided by Qualio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Qualio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

In this episode we interview Mark McDonough, the CEO of ChromaCode. The episode explores McDonough's journey to ChromaCode, from his early career as a naval officer to his roles at various medical and diagnostic companies. Under McDonough's leadership, ChromaCode has excelled in creating a high-definition PCR platform which enables fast, accurate, and affordable cancer diagnosis. The platform is particularly beneficial as it requires less patient tissue, provides rapid results, and has a lower cost than traditional diagnostic methods. McDonough also discusses the importance of partnerships in their go-to-market strategy and shared his insights on hiring and team development in today's competitive market. Looking ahead, ChromaCode expects to become a leader in developing innovative products for disease diagnosis, with a focus on patient-centered outcomes.
https://www.chromacode.com/

https://www.linkedin.com/in/mark-mcdonough-b1055216/

00:00 Introduction to the Podcast
00:40 Meet the Guest: Mark McDonough, CEO of ChromaCode
01:47 Mark's Journey to ChromaCode
06:05 Insights on Leadership and Building High Performing Teams
08:10 ChromaCode's Innovative Approach to PCR Testing
10:36 ChromaCode's Contribution to Precision Medicine
13:50 The Importance of Partnerships in ChromaCode's Strategy
16:33 Future Prospects for ChromaCode
18:27 Getting to Know Mark: Personal Interests
19:13 Closing Remarks and Contact Information
About Mark McDonough
Mark has over 25 years of experience helping build high growth HealthCare organizations. He is passionate about his team, his customers, and the patients that he and they are privileged to help serve. He most recently was the CEO of Pierian (now Velsera) which he led to a successful sale to Summa Equity, a private equity firm, in 2022. Prior to Pierian, he led CombiMatrix for five years, culminating in a sale to Invitae in 2017. Over his career, Mark has held various executive and commercial positions, and served as a US Naval Officer.

Qualio website:
https://www.qualio.com/

Previous episodes:
https://www.qualio.com/from-lab-to-launch-podcast

Apply to be on the show:
https://forms.gle/uUH2YtCFxJHrVGeL8

Music by keldez

  continue reading

101 episoade

Artwork
iconDistribuie
 
Manage episode 402773211 series 2833485
Content provided by Qualio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Qualio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

In this episode we interview Mark McDonough, the CEO of ChromaCode. The episode explores McDonough's journey to ChromaCode, from his early career as a naval officer to his roles at various medical and diagnostic companies. Under McDonough's leadership, ChromaCode has excelled in creating a high-definition PCR platform which enables fast, accurate, and affordable cancer diagnosis. The platform is particularly beneficial as it requires less patient tissue, provides rapid results, and has a lower cost than traditional diagnostic methods. McDonough also discusses the importance of partnerships in their go-to-market strategy and shared his insights on hiring and team development in today's competitive market. Looking ahead, ChromaCode expects to become a leader in developing innovative products for disease diagnosis, with a focus on patient-centered outcomes.
https://www.chromacode.com/

https://www.linkedin.com/in/mark-mcdonough-b1055216/

00:00 Introduction to the Podcast
00:40 Meet the Guest: Mark McDonough, CEO of ChromaCode
01:47 Mark's Journey to ChromaCode
06:05 Insights on Leadership and Building High Performing Teams
08:10 ChromaCode's Innovative Approach to PCR Testing
10:36 ChromaCode's Contribution to Precision Medicine
13:50 The Importance of Partnerships in ChromaCode's Strategy
16:33 Future Prospects for ChromaCode
18:27 Getting to Know Mark: Personal Interests
19:13 Closing Remarks and Contact Information
About Mark McDonough
Mark has over 25 years of experience helping build high growth HealthCare organizations. He is passionate about his team, his customers, and the patients that he and they are privileged to help serve. He most recently was the CEO of Pierian (now Velsera) which he led to a successful sale to Summa Equity, a private equity firm, in 2022. Prior to Pierian, he led CombiMatrix for five years, culminating in a sale to Invitae in 2017. Over his career, Mark has held various executive and commercial positions, and served as a US Naval Officer.

Qualio website:
https://www.qualio.com/

Previous episodes:
https://www.qualio.com/from-lab-to-launch-podcast

Apply to be on the show:
https://forms.gle/uUH2YtCFxJHrVGeL8

Music by keldez

  continue reading

101 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință